Human Papillomavirus Infection
📧 Sign up to get email alerts when something new happens for Human Papillomavirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: A Safety and Efficacy Study of TALEN and CRISPR/Cas9 in the Treatment of HPV-related Cervical Intraepithelial NeoplasiaⅠ [Phase 1]
Phase 1 clinical trial evaluating TALEN and CRISPR/Cas9 gene-editing approaches to treat HPV-related cervical intraepithelial neoplasia I, f…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A) [Phase 1]
Phase 1 trial assessing safety and immunogenicity of a GlaxoSmithKline HPV vaccine (GSK1674330A) in healthy young adult women is completed.
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Tailoring of Vaccine-Focused Messages: Disease Salience [NA]
Emory University conducted a study evaluating tailored vaccine-focused messages for disease salience related to Human papillomavirus infecti…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Testing the Use of Prompts to Increase Adolescent Immunization Rates [NA]
A UCLA-led completed trial tested whether prompts can increase adolescent vaccination uptake for vaccines including meningococcal disease, H…
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18. [Phase 3]
A Phase 3 trial by GlaxoSmithKline evaluating the safety and immunogenicity of the HPV-16/18 vaccine in young adolescent women has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time
This clinical trial update reports that the HPV oral transmission study in partners has completed. The sponsor is Johns Hopkins Bloomberg Sc…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV
The study investigated correlates of oral human papillomavirus (HPV) infection in adolescents and young adults with behaviorally acquired HI…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: AFIX to Improve HPV Vaccination [NA]
The University of North Carolina, Chapel Hill trial evaluated the AFIX quality-improvement approach to increase HPV vaccination uptake and h…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Human Papillomavirus and Rate of Pregnancy Achieved Via Medically Assisted Procreation
A completed clinical trial investigates whether human papillomavirus infection influences the rate of pregnancy achieved through medically a…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System [Phase 3]
Phase 3 trial evaluating the APTIMA HPV Assay on the TIGRIS System for detecting human papillomavirus infection. The study is completed with…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL [Phase 2]
A completed Phase II trial evaluating a therapeutic vaccine for human papillomavirus infection in women with normal cytology or ASCUS/LSIL.
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL [Phase 1]
A Phase 1 trial of the GTL001 vaccine with imiquimod adjuvant in HPV 16/18-infected women aged 25–65 with normal cytology, ASCUS, or LSIL wa…
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years [Phase 3]
This Phase 3 clinical trial update reports immunogenicity and safety data for GlaxoSmithKline's HPV vaccine in healthy women aged 18-35, and…
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults [Phase 2]
A Phase 2 follow-up study by GlaxoSmithKline Biologicals evaluating the HPV vaccine to prevent cervical HPV infection in young adults has co…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts [Phase 4]
Phase 4 randomized trial evaluating 400 mg of oral zinc gluconate as adjunctive therapy for genital warts (HPV-related) was terminated.
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Genital HPV Infections Before and After Renal Transplantation
A completed clinical trial evaluating genital human papillomavirus infections in individuals before and after renal transplantation.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: The HPV Self-test as a Test of Cure in Madagascar [NA]
A completed clinical trial in Madagascar evaluated using an HPV self-test as a test of cure for human papillomavirus infection and cervical …
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: A Phase I Clinical Trial of an HPV Therapeutic Vaccine [Phase 1]
A Phase I clinical trial of an HPV therapeutic vaccine sponsored by the University of Arkansas has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of GlaxoSmithKline's HPV vaccine in females aged 10-14; the study has been completed.
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women. [Phase 2]
Takeda-sponsored Phase 2 trial of 851B Gel for high-risk cervical human papillomavirus infection in women has been terminated, with no effic…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females [Phase 2]
Phase 2 safety and immunogenicity study of MEDI-517 (GSK 580299) with or without adjuvant in healthy adult females has completed. The trial …
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females [Phase 2]
Phase 2 dose-comparison study of MEDI-517 (GSK 580299) in healthy adult females has completed. The trial evaluated safety and immunogenicity…
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: An HPV Vaccine Provider Intervention in Safety Net Clinics [NA]
This Clinical Trial Update reports the completion of a study evaluating an HPV vaccine provider intervention in safety net clinics, aiming t…
-
CLINICAL_TRIALS trial_result · 2016-09-13Clinical Trial Update: A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection [NA]
This clinical trial update reports on a completed study comparing cotton and flocked vaginal self-collection swabs for HPV testing.
-
CLINICAL_TRIALS trial_result · 2016-09-12Clinical Trial Update: Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18 [Phase 3]
Phase 3 trial by GlaxoSmithKline evaluating consistency and non-inferiority of the HPV-16/18 vaccine in young adult women has completed.